头孢哌酮舒巴坦和左氧氟沙星治疗老年社区获得性肺炎的效果对比被引量：7

导出

摘要目的:探究头孢哌酮舒巴坦和左氧氟沙星治疗老年社区获得性肺炎的效果。方法:回顾性分析2015年6月～2017年6月本院收治的70例老年社区获得性肺炎患者,根据治疗方式分为参照组、研究组,分别采取左氧氟沙星、头孢哌酮/舒巴坦药物治疗,经14d治疗对比两组治疗效果。结果:研究组治疗总有效率94.29%显著高于参照组的77.14%,P<0.05。治疗3d、7d、14d时,研究组炎性因子(PCT、CRP、WBC)水平均显著低于参照组,差异有统计学意义(P<0.05)。结论:相比左氧氟沙星,采取头孢哌酮舒巴坦治疗老年社区获得性肺炎的临床效果更为显著。

作者张洁宋晓晓陈苗

机构地区河南省焦作市人民医院

出处《北方药学》 2019年第1期53-53,52,共2页 Journal of North Pharmacy

关键词头孢哌酮舒巴坦左氧氟沙星老年社区获得性肺炎效果炎性因子水平

分类号 R563.1 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献5

1时俊霞,秦文婧,徐欣,王芳,梁宇.头孢哌酮/舒巴坦治疗老年社区获得性肺炎的疗效及对炎性因子水平的影响[J].中华医院感染学杂志,2016,26(16):3690-3692. 被引量：23
2梁秀胡,蓝能,周艳吉.头孢哌酮/舒巴坦和左氧氟沙星治疗老年社区获得性肺炎的效果对比及对炎性因子水平的影响[J].右江医学,2017,45(3):324-327. 被引量：11
3葛祥.替加环素联合头孢哌酮-舒巴坦治疗广泛耐药鲍曼不动杆菌感染的医院获得性肺炎效果观察[J].中国乡村医药,2017,24(20):40-41. 被引量：2
4朱海花.氨溴索联合头孢哌酮舒巴坦治疗社区获得性肺炎的临床疗效及C反应蛋白的影响[J].中外医疗,2017,36(8):131-132. 被引量：4
5张宁,王颖,刘衍霖.银翘散联合头孢哌酮/舒巴坦治疗社区获得性肺炎患者的疗效及安全性分析[J].国际医药卫生导报,2015,21(23):3478-3480. 被引量：2

二级参考文献48

1王旭东.医院获得性肺炎[J].中国临床医生杂志,2005,33(1):15-16. 被引量：14
2Proshchaev KI,Zabinyakov NA,Azarov KS,et al.Studies of the structure and functions of blood cells in senile patients with pneumonia on the biological model of hypoxia by scanning probe microscopy[J].Bull Exp Biol Med,2014,158(2):256-259.
3Kumagai S,Ishida T,Tachibana H,et al.Polybacterial aetiology and outcomes in patients with community-acquired pneumonia[J].Int J Tuberc Lung Dis,2016,20(1):129-135.
4Chatterjee AB.Review:Corticosteroids reduce mechanical ventilation and ARDS in inpatients with community-acquired pneumonia[J].Ann Intern Med,2015,163(12):JC2.
5Panchabhai TS,Khabbaza JE,Raja S,et al.Extracorporeal membrane oxygenation and toilet bronchoscopy as a bridge to pneumonectomy insevere community-acquired methicillin-resistant Staphylococcus aureus pneumonia[J].Ann Thorac Med,2015,10(4):292-294.
6Kaya S,Telci Caklili O,Oguz A.Community-acquired pneumonia requiring hospitalization[J].N Engl J Med,2015,373(24):2381.
7Ariza-Prota MA,Pando-Sandoval A,Fole-Vázquez D,et al.Community-acquired bacteremic Streptomyces atratus pneumonia in an immunocompetent adult:a casereport[J].J Med Case Rep,2015(9):262.
8Kl Soylar,Kln O,Ellidokuz H.Comparison of the combination and quinolone therapy in community acquired pneumonia[J].Tuberk Toraks,2015,63(3):165-169.
9Dantsev VV,Golota AS,Karpuschenko VG,et al.The modern state and improvement prospects of community-acquired pneumonia and pulmonary tuberculosis differential diagnostics[J].Voen Med Zh,2015,336(5):29-36.
10Gubbins PO,Li C.The influence of influenza and pneumococcal vaccines on community-acquired pneumonia(CAP)outcomes among elderly patients[J].Curr Infect Dis Rep,2015,17(12):49.